Archives

LOS ANGELES—A recombinant form of the human hormone relaxin — active in pregnancy to optimise the mother’s cardiovascular capacity — may help patients hospitalised for acute heart failure, accor

LOS ANGELES—Direct infusions of human HDL — to speedily boost HDL levels —could be an answer to preventing re-infarction in patients who’ve just had a heart attack and are at high risk of having

Other headlines: – Tapering, TNF-inhibitor drugs is possible in people with rheumatoid arthritis in remission. – TNF-inhibitors reduce the need for hospitalisation and surgery. – Pat

LOS ANGELES—Aspirin has a new role: in preventing recurrent thromboembolism among patients who are not candidates for anti-coagulation — according to conclusions from the ASPIRE study reported to the

LOS ANGELES—The “polypill” — a multi-drug pill — combining diuretic, ACE inhibitor, beta-blocker, statin and aspirin — brings even more benefit when it’s targeted at patients who are

LOS ANGELES—The optimal revascularisation strategy for patients with diabetes and multi-vessel coronary disease was confirmed to be coronary artery bypass grafting rather than PCI at the American Hear

Other headlines: – New monoclonal antibody reduces LDL-cholesterol in statin-intolerant patients. – Aspirin effective for extended treatment of venous thromboembolism. – Breast cance

BANGKOK—60 million lives could be saved — most of them in low- and middle-income countries — by taking effective measures to combat any future pandemic of influenza.

BANGKOK AND PHNOM PENH—Protecting the planet from infections such as influenza is the mission of a dedicated team of scientists working for the London School of Hygiene & Tropical Medicine workin

PHNOM PENH, CAMBODIA—Scientists from the London School of Hygiene & Tropical Medicine are working along the Thai-Cambodian border: the ‘epicentre’ of resistance to artemisinin combina

LONDON—Double-action preventive therapy for pregnant women could prevent the large numbers of stillbirths and neonatal deaths presently being caused by malaria and

LONDON—A man with no legs and only one arm and a boy crippled by polio have been instrumental in steering a Red Cross team’s work in Afghanistan. The ICRC’s head of Orthopaedics in Kabul,

LONDON—A case report in The Lancet has highlighted the threat of fake drugs for malaria — the subject of intensive research at the London School of Hygiene & Tropical Medicine. Dr Harparkash Kaur

LONDON—The health impact of diet and physical activity may play a part in the marked ethnic differences in type 2 diabetes and cardiovascular disease in the UK according to research reported at the Lo

LONDON—People are now routinely using the internet to find out about health conditions and to share their own experiences with others with similar diagnoses. This is a radical change in how people exp

SINGAPORE—Two important universities are teaming-up to face the challenge of the most significant threats to global health today. The London School of Hygiene & Tropical Medicine and the Saw Swee

LONDON—A detailed economic analysis suggests that billions of dollars could be saved from health-care budgets around the world if people cycled an average of around three kilometres a day and doubled

RIO DE JANEIRO and LONDON—A call for action on global health has been made in an article published by The Lancet medical journal about the United Nations Conference on Sustainable Development held in

LONDON—One in twenty deaths in English hospitals could be prevented according to research published in the British Medical Journal Quality and Safety. Dr Helen Hogan of the London School of Hygiene &#

LONDON—Family planning is a key priority for fulfilling global development goals, according to researchers writing in a special series of The Lancet medical journal coinciding with the London Summit o

CHICAGO—The outgoing president of ASCO, Dr Michael Link from Stanford University School of Medicine in California, answers questions from Peter Goodwin about the progress achieved in cancer clinical s

CHICAGO—Findings from a Phase III trial show that initial single-agent therapy with a new oral drug called afatinib prolongs progression- free survival in patients with advanced lung adenocarcinomas t

CHICAGO—At the Plenary Session of ASCO Maha Hussain MD, FACP of the University of Michigan in Ann Arbor presented results from a long-term, multicenter Phase III international clinical trial comparing

STOCKHOLM—The first specialist in pediatric oncology ever to hold office as President of the American Society of Clinical Oncology, Dr Michael Link — Professor of Pediatrics at Stanford University Sch

The experience of pilgrims going to Mecca can help prepare London to host a healthy Olympic Games, according to Dr Ahmad Moolla the London medic and researcher who organised a special expert panel dis